Profil News

Our expert

Dr. Lars Bochmann

Director Marketing & Business Development

June 2, 2020

Profil World - The clinical diabetes research newsletter - June 2020

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Free

May 26, 2020

When Artificial Intelligence and Artificial Pancreas meet

How machine learning methods are changing diabetes research and diabetes care When voice assistants tell us what the weather will be like, when self-driving cars steer through dense city traffic, or

May 6, 2020

Non invasive CGM; hope at the horizon?

Non-invasive Continuous Glucose Monitoring (niCGM) is the holy grail of glucose monitoring. But the quest has been arduous so far; research carried out over the past 35 years has not resulted in in a

April 21, 2020

Free webinar on insulin biosimilars

Profil continues the successful series of scientific webinars. On My 19th, 2020 we will air our free webinar on insulin biosimilars. The session is presented by Dr. Tim Heise, Lead Scientist and

March 31, 2020

Think Tank highlights CROs role the adoption of AI-powered health innovation

In recent years there has been rapid growth in the field of medical and health technology. Not only the number of players in this sector has increased over time, but the type of products and services

March 20, 2020

Fighting Corona: Profil's contribution

The pandemic of the coronavirus disease (COVID-19) has rapidly changed our lives. Most facilities of daily life are closed, many people try to get accustomed to home-office and in many countries

March 17, 2020

Clinical study shows better clamp quality with Clamp-PID algorithm

Introduction The glucose clamp is the gold standard for the determination of pharmacokinetic and pharmacodynamic effects of anti-diabetic drugs (e.g. insulins). During a typical glucose clamps the

March 3, 2020

A novel method to determine the pharmacodynamic onset of action of prandial insulins

Introduction In order to improve postprandial glycemic control, new insulins are developed, with earlier glucose lowering action by advancing the time to onset of action [1, 2, 3]. The standard for

February 18, 2020

Profil World - The clinical diabetes research newsletter - February 2020

Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. Upcoming